With some of the world's leading neuroscientists and machine learning researchers, Columbia is seeking lessons from biology that can create AI systems as versatile and efficient as our brains.
By studying the gaze of experts as they assess images of the eye, data scientist Kaveri Thakoor has improved AI methods for glaucoma detection and developed a new way to instruct trainees.
Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.
The fluctuations of gut microbial communities follow ecological principles developed for animals and financial markets, which may help to predict disease biomarkers and effects of unhealthy diets.
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
CUIMC biologists developed a computer algorithm that uncovered previously unknown interactions between viruses and human proteins, providing new insights into Zika and HPV.
With a genome that’s regularly broken into 225,000 pieces and reassembled, a pond protist may be the perfect creature to teach us how genomic stability—often lost in cancer—is maintained.